Intercellular adhesion molecule-1 (ICAM-1) and its receptors are adhesion molecules that play a key role in the transmigration of inflammatory cells through the blood-brain barrier, one of the earliest events in multiple sclerosis (MS), which leads to demyelination in the central nervous system. To investigate the role of genes encoding ICAM-1 and its receptors, we used a strategy of genetic linkage and association in 439 case-parent MS families of French origin, well characterized according to HLA status and severity. We demonstrate that the genes encoding ICAM-1 receptors do not influence MS susceptibility or severity. ICAM-1 had a modest, but significant effect on MS genetic susceptibility, independent of HLA and disease severity. We observed a rare, and an as yet unreported, ICAM-1 gene haplotype defined by amino acids K469 and R241 that was never transmitted to patients suggesting a protective effect against MS in our population.
Multiple sclerosis (MS) is the most common neurological disease in young adults and is characterized by a complex and multifactorial pathogenesis. Numerous studies have shown that both genetic and environmental factors contribute to an increased risk of developing MS. 1, 2 Little is known, however, about the exact nature of the involved genetic factors, except for the role of HLA Class II with, in most populations, an association found with the DR2 allele. The role of environmental exposures, hypothetically viral infection, which causes inflammation and demyelination in the central nervous system (CNS) of MS patients has also been suggested but remains unclear.
The infiltration of inflammatory cells into the CNS is considered to be one of the earliest events in the formation of a plaque, the fundamental pathological lesion in MS. Inflammatory cells, activated by poorly understood mechanisms, enter the brain by crossing the blood-brain barrier (BBB) through a complex cascade of molecular events in which adhesion molecules are keyplayers. 3, 4 Adhesion molecules, induced at the surface of endothelial cells by cytokines released by T lymphocytes and macrophages, allow transmigration of inflammatory cells across the BBB, leading to demyelination. 5 Molecules that contribute to this mechanism are well characterized. 6, 7 Several reports have shown that intercellular adhesion molecule 1 (ICAM-1), which is expressed at the surface of endothelial cells, has a prominent role in facilitating the entrance of inflammatory cells into the CNS. [8] [9] [10] ICAM-1 is a ligand of lymphocyte function-associated antigen-1 (LFA-1 or CD11a/CD18 or a L b 2 ) and Mac-1 (CD11b/CD18 or a M b 2 ), two receptors localized to the membrane of inflammatory cells. 11, 12 Studies of the interaction between ICAM-1 and its receptors have demonstrated that both LFA-1 and Mac-1 contribute equally to adhesion efficiency during transendothelial migration of neutrophils. 13, 14 ICAM-1 has also been described as the major receptor for rhinovirus, 15, 16 strengthening the interest in this gene, according to the viral hypothesis of MS.
Because of the key role of ICAM-1 in BBB physiology, genetic variations in its gene or in the genes coding for its receptors may be involved in MS susceptibility and/or severity. Conflicting results on the role of ICAM-1 in MS susceptibility have been reported. An association was first reported with the allele K469 of an intragenic SNP of ICAM-1 on a Polish sample of cases and controls. 17 This association was not replicated in subsequent studies using different samples of cases and controls 18, 19 and in a meta-analysis combining the sample of Luomala and co-workers and the initial sample. 20 Moreover, no association was found with another intragenic SNP (SNP G/R 241).
In this study, we investigate the association between ICAM-1 and MS in a large population of French MS case-parent trios, using two single nucleotide polymorphisms and one microsatellite ( Table 1) . We also study the role of genes coding for ICAM-1 receptors LFA-1 and MAC-1 that have never been studied before in relation to MS susceptibility or severity (six SNPs, Table 1 ). Using a strategy of multilocus genetic analysis, we report the association of a protective ICAM-1 haplotype against MS in this population.
To test for genetic association with the disease, the transmission disequilibrium test (TDT) was performed at each locus. 21 This test focuses on heterozygous parents and compares alleles transmitted and nontransmitted to affected offspring. For ICAM-1, each marker was tested individually but also in relation with the other markers by looking at the haplotype distribution. It has been shown that haplotype tests may be more powerful at detecting the role of a given genomic region in disease susceptibility than single-locus methods. [22] [23] [24] [25] Indeed, disease susceptibility may be due to the combined effects of multiple sequence variants.
To control for the numerous tests performed, we adopted a strategy in two steps. All the markers were tested in a first subset of 150 families referred to as batch 1. For such a sample size, the probability to detect a locus with a genotype relative risk of 2 (assuming a multiplicative model) for a nominal type I error of 5% is greater than 80%. 26 When for a marker, the uncorrected P-value was below 5% in batch 1, the remaining 289 case-parent families (batch 2) were tested.
A total of 439 case-parent MS families, all comprising one affected child with definite MS 27, 28 and his two parents, were recruited throughout France by the French Multiple Sclerosis Genetic Group as previously described. 29, 30 Informed written consent was obtained from each individual participating in the study in accordance with the Helsinki Convention and the French law relating to biomedical research. Geographic and ethnic origin, sex, age at onset, duration of the disease, disease course and disease severity as measured by the Expanded Disability Status Scale (EDSS) 31 were recorded for each patient. Since we have previously demonstrated that familial factors contribute to MS severity, 32 we stratified our sample based on severity. We used the progression index (PI) defined as the ratio of the EDSS vs disease duration (in years) for patients with a disease duration of 5 years or more. 32 Patients with a PI less than 0.4 and over 0.4 were classified as mild and severe, respectively. Among the 430 patients with information on PI, 250 were classified as mild and 180 as severe.
HLA Class II DR alleles were determined for 429 out of the 439 patients. Since HLA-DR2 allele is associated with MS, 33 we have also stratified our sample according to whether or not the proband was a carrier of the HLA Class II DR2 allele (among the 429 patients genotyped for HLA, 223 (52%) were carriers). The demographic characteristics of our population are similar to published series. There was a female preponderance (68%) and the mean age at onset was 26 years (standard deviation (s.d.) ¼ 7). The mean duration of the disease was 9 years (s.d. ¼ 7) and the mean EDSS was 3.5 (s.d. ¼ 2).
Parental transmitted and nontransmitted allele frequencies of CD18, CD11a, CD11b and ICAM-1 gene polymorphisms are presented in Table 2 . With regard to the frequencies of the ICAM-1 microsatellite alleles, there were 7, 85 and 8% of alleles 1, 2 and 3 respectively, considering the nontransmitted parental alleles. There were 5, 86 and 9 of alleles 1, 2 and 3, respectively, considering patient alleles.
Performing single-locus TDT on batch 1 for CD18, CD11a and CD11b genes, no association was found with MS susceptibility with or without stratification on HLA status and on disease severity (data not shown). For the ICAM-1 gene, there was a difference in batch 1 in the distribution between transmitted and nontransmitted . Genotypes of the SNP were assessed using either a single labeled base extension method for an ABI PRISM 377 sequencer (SnaPshot) (ICAM1, CD18 and CD11a) or a 5 0 nuclease assay on an ABI 7000 sequence detection system (CD11b) (Applied Biosystems, USA).
Intercellular adhesion molecule-1 I Cournu-Rebeix et al alleles at the microsatellite marker. One of the alleles of the microsatellite (allele 1 that has never been reported before) was significantly less transmitted and, conversely, one of the alleles (allele 2) was more transmitted to affected offspring (Table 3) .
According to our decision criteria for the two-step analysis, only the microsatellite should then be tested on batch 2 (289 families). However, we decided to also genotype the different individuals at the two ICAM-1 intragenic SNPs, in order to obtain some haplotypic information. The results are presented in Table 3 . When the loci were studied individually, no difference was found on the allele transmissions from heterozy gous parents to affected offspring in batch 2 and in the entire population (batch 1+batch 2) at any of the tested markers. However, after stratification on HLA status, a lack of transmission of the CA-repeat allele 1 could be observed in DR2+families (uncorrected P ¼ 0.04) but there was no significant difference in the transmissions of this allele to DR2+ and DR2À patients (w 2 tests).
For the frequent three-locus haplotypes, no significant difference was observed between the number of transmissions and nontransmissions from heterozygous parents to affected offspring (data not shown). For rarer haplotypes, however, we observed a lack of transmission of one haplotype, R241/K469/2. This particular haplotype was indeed found in four families and never transmitted to affected offspring. This same combination R241 and K469 was also observed in three other families in which it was never transmitted to the affected child. In one family, it was associated to allele 3 at the CA repeat and in the two other families, no typing was available for the CA repeat. Thus, we show that the ICAM-1 haplotype defined by R241 and K469 is found in seven informative families and is never transmitted from parents to affected children (TDT ¼ 7, binomial exact test P ¼ 0.01) (Figure 1 In this article, we report a genetic study of ICAM-1 and its receptors as candidates for MS genes. We took advantage of a large cohort of case-parent MS families of French origin to look for both linkage and association between markers of these candidate genes and MS. No association between MS and genes encoding ICAM-1 receptors was detected. However, we found that one haplotype of the ICAM-1 gene formed by the combination of allele R at position 241 in exon 4 and allele K at position 469 in exon 6 was never transmitted to affected offspring, suggesting that this haplotype may be protective against MS.
ICAM-1 gene is located on chromosome 19 p13, a region identified as of possible significance in two independent screenings in MS families. 34, 35 Previous studies have addressed the role of ICAM-1 in MS genetics with conflicting results. One study, performed on case-controls of Polish origin, found a genetic association with ICAM-1 K469. 17 This result was not confirmed in three subsequent studies. [18] [19] [20] However, except for the study of Marrosu et al, 19 no multilocus analysis of the two SNPs was performed. In the study by Marrosu et al, 19 haplotypes were studied but the particular haplotype we evidenced here was not observed probably because of the small sample size. 19 The ICAM-1 molecule consists of five immunoglobulin-like (Ig) domains (Ig-1 to Ig-5), each of them encoded by its own exon. Exon 4 polymorphism (G/R241) changes an arginine into a lysine in domain Ig-3. Exon 6 polymorphism (K/E469) substitutes a glutamic acid to a lysine in Ig-like domain 5. To explain the protective effect of the R241/K469 haplotype in MS, we propose two hypotheses. The first postulates a decreased binding efficacy of ICAM-1 to its ligands Mac-1 and LFA-1. Accordingly, the binding site of Mac-1 to ICAM-1 is located within Ig-3 domain. It has also been shown that, although domain Ig-1 contains the major binding site for LFA-1 to ICAM-1, Ig-3, Ig-4 and Ig-5 were also important for the accessibility of LFA-1 binding site, decreasing the efficacy of the interaction several fold. 36 The second hypothesis relates to the role of ICAM-1 as a viral receptor. ICAM-1 has been shown to be an important receptor for the majority of human rhinoviruses, an interaction that initiates entry of the virus into the host cell. 15, [37] [38] [39] Mutational and antigenic analyses localized the rhinovirus binding site to domain Ig-1 of ICAM-1 and demonstrated that Ig-3, Ig-4 and Ig-5 domains are also important for the accessibility of the rhinovirus binding site. 36, 40 Therefore, a combination of allele K469 and R241 in domain Ig-5 and Ig-3, respectively, of ICAM-1 molecule may influence susceptibility to viral infection, an often suspected environmental factor in MS pathophysiology.
In conclusion, in a large population of MS case-parent trios, we found that a particular haplotype of ICAM-1 may have a protective role in MS. Although this haplotype is a rare haplotype, the association is strong enough to be detected in the French population.
